-
1
-
-
0028114478
-
In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus
-
Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:2553-2556.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 2553-2556
-
-
Barchiesi, F.1
Colombo, A.L.2
McGough, D.A.3
Fothergill, A.W.4
Rinaldi, M.G.5
-
2
-
-
0028287818
-
In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus
-
Barchiesi, F., A. L. Colombo, D. A. McGough, A. W. Fothergill, and M. G. Rinaldi. 1994. In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother. 38:1530-1533.
-
(1994)
Antimicrob. Agents Chemother.
, vol.38
, pp. 1530-1533
-
-
Barchiesi, F.1
Colombo, A.L.2
McGough, D.A.3
Fothergill, A.W.4
Rinaldi, M.G.5
-
3
-
-
0029799501
-
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species
-
Barry, A. L., and S. D. Brown. 1996. In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob. Agents Chemother. 40:1948-1949.
-
(1996)
Antimicrob. Agents Chemother.
, vol.40
, pp. 1948-1949
-
-
Barry, A.L.1
Brown, S.D.2
-
4
-
-
0027360244
-
Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1
-
Cameron, M. L., W. A. Schell, S. Bruch, J. A. Bartlett, H. A. Waskin, and J. R. Perfect. 1993. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 37: 2449-2453.
-
(1993)
Antimicrob. Agents Chemother.
, vol.37
, pp. 2449-2453
-
-
Cameron, M.L.1
Schell, W.A.2
Bruch, S.3
Bartlett, J.A.4
Waskin, H.A.5
Perfect, J.R.6
-
5
-
-
0342908293
-
Treatment of fluconazole (FCZ) resistant (res) oral candidosis (OC) with D0870 in patients with AIDS (PWA)
-
abstr. M89, American Society for Microbiology, Washington, D.C.
-
Cartledge, J. D., D. Denning, B. Dupont, N. Clumeck, S. De Wit, D. A. Hawkins, and B. G. Gazzard. 1994. Treatment of fluconazole (FCZ) resistant (res) oral candidosis (OC) with D0870 in patients with AIDS (PWA), abstr. M89, p. 248. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1994)
Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 248
-
-
Cartledge, J.D.1
Denning, D.2
Dupont, B.3
Clumeck, N.4
De Wit, S.5
Hawkins, D.A.6
Gazzard, B.G.7
-
6
-
-
0028216481
-
Itraconazole cyclodextrin solution - Effective treatment for HIV-related candidosis unresponsive to other azole therapy
-
Letter
-
Cartledge, J. D., J. Midgley, M. Youle, and B. G. Gazzard. 1994. Itraconazole cyclodextrin solution - effective treatment for HIV-related candidosis unresponsive to other azole therapy. J. Antimicrob. Chemother. 33:1071-1073. (Letter.)
-
(1994)
J. Antimicrob. Chemother.
, vol.33
, pp. 1071-1073
-
-
Cartledge, J.D.1
Midgley, J.2
Youle, M.3
Gazzard, B.G.4
-
7
-
-
0000395961
-
UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Antifungal activity and selectivity in vitro
-
abstr. F72, American Society for Microbiology, Washington, D.C.
-
Hitchcock, C. A., G. W. Pye, G. P. Oliver, and P. F. Troke. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro, abstr. F72, p. 125. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1995)
Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 125
-
-
Hitchcock, C.A.1
Pye, G.W.2
Oliver, G.P.3
Troke, P.F.4
-
8
-
-
0028927789
-
Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis
-
Johnson, E. M., D. W. Warnock, J. Luker, S. R. Porter, and C. Scully. 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35:103-114.
-
(1995)
J. Antimicrob. Chemother.
, vol.35
, pp. 103-114
-
-
Johnson, E.M.1
Warnock, D.W.2
Luker, J.3
Porter, S.R.4
Scully, C.5
-
10
-
-
0026667777
-
Standardized susceptibility testing of fluconazole: An international collaborative study
-
Pfaller, M. A., B. Dupont, G. S. Kobayashi, J. Müller, M. G. Rinaldi, A. Espinel-Ingroff, S. Shadomy, P. F. Troke, T. J. Walsh, and D. W. Warnock. 1992. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob. Agents Chemother. 36:1805-1809.
-
(1992)
Antimicrob. Agents Chemother.
, vol.36
, pp. 1805-1809
-
-
Pfaller, M.A.1
Dupont, B.2
Kobayashi, G.S.3
Müller, J.4
Rinaldi, M.G.5
Espinel-Ingroff, A.6
Shadomy, S.7
Troke, P.F.8
Walsh, T.J.9
Warnock, D.W.10
-
11
-
-
0028006489
-
Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: Documentation by in vitro susceptibility testing and DNA subtype analysis
-
Redding, S., J. Smith, G. Farinacci, M. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
-
(1994)
Clin. Infect. Dis.
, vol.18
, pp. 240-242
-
-
Redding, S.1
Smith, J.2
Farinacci, G.3
Rinaldi, M.4
Fothergill, A.5
Rhine-Chalberg, J.6
Pfaller, M.7
-
12
-
-
0028817337
-
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia
-
Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb for the NIAID Mycoses Study Group and the Candidemia Study Group. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 40-44
-
-
Rex, J.H.1
Pfaller, M.A.2
Barry, A.L.3
Nelson, P.W.4
Webb, C.D.5
-
13
-
-
0028001183
-
Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection
-
Ruhnke, M., A. Eigler, I. Tennagen, B. Geiseler, E. Engelmann, and M. Trautmann. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098.
-
(1994)
J. Clin. Microbiol.
, vol.32
, pp. 2092-2098
-
-
Ruhnke, M.1
Eigler, A.2
Tennagen, I.3
Geiseler, B.4
Engelmann, E.5
Trautmann, M.6
-
14
-
-
0002039234
-
UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Activity in systemic candidiasis models and early clinical efficacy in oropharyngeal candidiasis (OPC)
-
abstr. F73, American Society for Microbiology, Washington, D.C.
-
Troke, P. F., K. W. Brammer, C. A. Hitchcock, S. Yonren, and N. Sarantis. 1995. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: activity in systemic candidiasis models and early clinical efficacy in oropharyngeal candidiasis (OPC), abstr. F73, p. 125. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1995)
Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 125
-
-
Troke, P.F.1
Brammer, K.W.2
Hitchcock, C.A.3
Yonren, S.4
Sarantis, N.5
-
15
-
-
0343343436
-
Standardised susceptibility testing of fluconazole: A nine centre, international collaborative study
-
abstr. 1596, American Society for Microbiology, Washington, D.C.
-
Troke, P. F., and the Fluconazole Susceptibility Testing Group. 1992. Standardised susceptibility testing of fluconazole: a nine centre, international collaborative study, abstr. 1596, p. 377. In Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
-
(1992)
Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy
, pp. 377
-
-
Troke, P.F.1
|